...
首页> 外文期刊>Scientific reports. >Multiplex Biomarker Screening Assay for Urinary Extracellular Vesicles Study: A Targeted Label-Free Proteomic Approach
【24h】

Multiplex Biomarker Screening Assay for Urinary Extracellular Vesicles Study: A Targeted Label-Free Proteomic Approach

机译:多重生物标志物筛查测定用于尿细胞外囊泡研究:无靶标记的无标记蛋白质组学方法

获取原文
           

摘要

The recent advance in targeted label-free proteomics, SWATH-MS, can provide consistent protein detection and reproducible protein quantitation, which is a considerable advantage for biomarker study of urinary extracellular vesicles. We developed a SWATH-MS workflow with a curated spectral library of 1,145 targets. Application of the workflow across nine replicates of three sample types (exosome-like vesicles (ELVs), microvesicles (MVs) and urine proteins (UPs)) resulted in the quantitation of 888 proteins at FDR 1%. The median-coefficient of variation of the 888 proteins in the ELV sample was 7.7%, indicating excellent reproducibility. Data analysis showed common exosome markers, (i.e. CD9, CD63, ALIX, TSG101 and HSP70) were enriched in urinary ELVs as compared to MVs and UPs. The use of a multiplex biomarker screening assay focused on ELVs was investigated, and perspectives in future applications are discussed.
机译:近期无靶标签蛋白质组学的进展,SWATH-MS,可以提供一致的蛋白质检测和可重复的蛋白质定量,这对于尿细胞外囊泡的生物标志物研究是相当大的优势。我们开发了一个带有1,145个目标的策划光谱库的SWATH-MS工作流程。在九种样品类型的九种样品(外泌体囊泡(ELV),微泡(MV)和尿蛋白(UPS))中的应用导致888蛋白在FDR <1%时的定量。 ELV样品中888蛋白的变异系数为7.7%,表明优异的再现性。数据分析显示常见的外出标记,(即CD9,CD63,Alix,TSG101和HSP70)与MV和UPS相比,富集尿ELV。研究了专注于ELV的多重生物标志物筛查检测,并讨论了未来申请的观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号